Calcipotriene/Betamethasone in the Treatment of Psoriasis: A Review Article

    Rosita Saraceno, Talia Gramiccia, Pasquale Frascione, Sergio Chimenti
    TLDR The combination of calcipotriene and betamethasone is more effective and has fewer side effects for treating psoriasis.
    Plaque-type psoriasis, affecting approximately 1-3% of the Caucasian population, was commonly treated with topical corticosteroids and vitamin D3 analogues. The combination of calcipotriene and betamethasone dipropionate optimized treatment by merging the keratinocyte differentiation and antiproliferative effects of vitamin D3 analogues with the anti-inflammatory properties of steroids. This combination enhanced effectiveness and reduced side effects compared to using a single topical agent. The review highlighted the benefits of this combination therapy for localized plaque-type, scalp, and nail psoriasis.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    2 / 2 results

      community DHT Harms Scalp Microbiome: DHT Itch is REAL

      in Research/Science  413 upvotes 1 week ago
      Increased Malassezia and Cutibacterium in the scalp microbiome are linked to higher sebum production and inflammation in androgenetic alopecia (AGA). Treatments include ciclopirox shampoo, benzoyl peroxide shampoo, clobetasol propionate, calcipotriol, minoxidil, finasteride, and dutasteride.

    Similar Research

    5 / 90 results